A detailed history of Ajo Vista, LLC transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Ajo Vista, LLC holds 10,319 shares of DSGN stock, worth $64,080. This represents 0.24% of its overall portfolio holdings.

Number of Shares
10,319
Holding current value
$64,080
% of portfolio
0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.19 - $5.88 $32,917 - $60,675
10,319 New
10,319 $55,000

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $347M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track Ajo Vista, LLC Portfolio

Follow Ajo Vista, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ajo Vista, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ajo Vista, LLC with notifications on news.